Coverage for Insurance Gaps

Enrolling in the GARDian program also provides you with a safety net in case you experience an insurance gap, if you are qualified.

For patients requiring IgG therapy who experience a lapse in insurance or who are uninsured while meeting the program's requirements, Baxter may provide GAMMAGARD LIQUID at no cost.*

FAQs

Get answers to your questions about the GARDian Program.

Learn More

Coverage for insurance gaps is available to qualified IgG patients on any therapy who enroll in the GARDian program. This includes newly diagnosed patients and those who are not currently using GAMMAGARD.

*Financial and residency requirements apply. Please contact the GARDian program for additional details.

Important Risk Information for GAMMAGARD LIQUID

In clinical trials, two serious events (two episodes of aseptic meningitis in one patient) were deemed to be possibly related to the infusion of GAMMAGARD LIQUID. Various mild and moderate reactions, such as headache, fever, fatigue, chills, flushing, dizziness, urticaria, wheezing or chest tightness, nausea, vomiting, rigors, back pain, chest pain, muscle cramps, and changes in blood pressure may occur with infusions of GAMMAGARD LIQUID.

Please see the detailed Important Risk Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] for full prescribing details.

Healthcare Professionals

Find out how the GARDian program can help you and your patients.

Learn More